19-3586545-G-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_133261.3(GIPC3):​c.276G>A​(p.Leu92Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.142 in 1,613,494 control chromosomes in the GnomAD database, including 23,097 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.23 ( 6459 hom., cov: 31)
Exomes 𝑓: 0.13 ( 16638 hom. )

Consequence

GIPC3
NM_133261.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.913

Publications

24 publications found
Variant links:
Genes affected
GIPC3 (HGNC:18183): (GIPC PDZ domain containing family member 3) The protein encoded by this gene belongs to the GIPC family. Studies in mice suggest that this gene is required for postnatal maturation of the hair bundle and long-term survival of hair cells and spiral ganglion in the ear. Mutations in this gene are associated with autosomal recessive deafness. [provided by RefSeq, Dec 2011]
GIPC3 Gene-Disease associations (from GenCC):
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive nonsyndromic hearing loss 15
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 19-3586545-G-A is Benign according to our data. Variant chr19-3586545-G-A is described in ClinVar as [Benign]. Clinvar id is 46571.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.913 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.511 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GIPC3NM_133261.3 linkc.276G>A p.Leu92Leu synonymous_variant Exon 2 of 6 ENST00000644452.3 NP_573568.1 Q8TF64
GIPC3NM_001411144.1 linkc.276G>A p.Leu92Leu synonymous_variant Exon 2 of 6 NP_001398073.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GIPC3ENST00000644452.3 linkc.276G>A p.Leu92Leu synonymous_variant Exon 2 of 6 NM_133261.3 ENSP00000493901.2 Q8TF64
GIPC3ENST00000644946.1 linkc.276G>A p.Leu92Leu synonymous_variant Exon 2 of 6 ENSP00000495068.1 A0A2R8Y651

Frequencies

GnomAD3 genomes
AF:
0.229
AC:
34745
AN:
151990
Hom.:
6432
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.517
Gnomad AMI
AF:
0.0800
Gnomad AMR
AF:
0.132
Gnomad ASJ
AF:
0.122
Gnomad EAS
AF:
0.0512
Gnomad SAS
AF:
0.121
Gnomad FIN
AF:
0.0837
Gnomad MID
AF:
0.149
Gnomad NFE
AF:
0.128
Gnomad OTH
AF:
0.187
GnomAD2 exomes
AF:
0.137
AC:
34256
AN:
250884
AF XY:
0.130
show subpopulations
Gnomad AFR exome
AF:
0.532
Gnomad AMR exome
AF:
0.0816
Gnomad ASJ exome
AF:
0.114
Gnomad EAS exome
AF:
0.0486
Gnomad FIN exome
AF:
0.0874
Gnomad NFE exome
AF:
0.126
Gnomad OTH exome
AF:
0.123
GnomAD4 exome
AF:
0.133
AC:
194965
AN:
1461386
Hom.:
16638
Cov.:
39
AF XY:
0.132
AC XY:
95623
AN XY:
727008
show subpopulations
African (AFR)
AF:
0.541
AC:
18112
AN:
33472
American (AMR)
AF:
0.0878
AC:
3925
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.113
AC:
2951
AN:
26132
East Asian (EAS)
AF:
0.0495
AC:
1965
AN:
39700
South Asian (SAS)
AF:
0.125
AC:
10822
AN:
86248
European-Finnish (FIN)
AF:
0.0897
AC:
4773
AN:
53182
Middle Eastern (MID)
AF:
0.147
AC:
849
AN:
5768
European-Non Finnish (NFE)
AF:
0.128
AC:
142394
AN:
1111786
Other (OTH)
AF:
0.152
AC:
9174
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
9385
18770
28155
37540
46925
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5338
10676
16014
21352
26690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.229
AC:
34820
AN:
152108
Hom.:
6459
Cov.:
31
AF XY:
0.222
AC XY:
16520
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.517
AC:
21424
AN:
41426
American (AMR)
AF:
0.132
AC:
2017
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.122
AC:
423
AN:
3472
East Asian (EAS)
AF:
0.0511
AC:
264
AN:
5166
South Asian (SAS)
AF:
0.121
AC:
584
AN:
4832
European-Finnish (FIN)
AF:
0.0837
AC:
889
AN:
10624
Middle Eastern (MID)
AF:
0.150
AC:
44
AN:
294
European-Non Finnish (NFE)
AF:
0.128
AC:
8711
AN:
67988
Other (OTH)
AF:
0.185
AC:
391
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1141
2282
3424
4565
5706
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
330
660
990
1320
1650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.151
Hom.:
5684
Bravo
AF:
0.244
Asia WGS
AF:
0.126
AC:
439
AN:
3478
EpiCase
AF:
0.128
EpiControl
AF:
0.126

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Feb 26, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 09, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Leu92Leu in Exon 02 of GIPC3: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue, is not located within the splice consensus sequence, and has been identified in 48.7% (1820/3738) of African American chromosomes from a broad population by the NHLBI Exome Sequenci ng Project (http://evs.gs.washington.edu/EVS; dbSNP rs8113232). -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
2.0
DANN
Benign
0.66
PhyloP100
0.91
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8113232; hg19: chr19-3586543; API